Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury.
about
Immune Activation in the Liver by Nucleic AcidsInterleukin-1 Family Cytokines in Liver DiseasesCurrent strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen speciesMechanisms of Cisplatin nephrotoxicityPAMPs and DAMPs as triggers for DICHeart-resident CCR2+ macrophages promote neutrophil extravasation through TLR9/MyD88/CXCL5 signaling.Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury.Toll-like receptors in pathophysiology of liver diseasesContribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosusEvolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.The Impact of Sterile Inflammation in Acute Liver Injury.Toll-like receptor 9 is required for opioid-induced microglia apoptosis.Toll-like receptor 9 in breast cancer.Systemic inflammation and liver injury following hemorrhagic shock and peripheral tissue trauma involve functional TLR9 signaling on bone marrow-derived cells and parenchymal cells.Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9.Biomarkers distinguish apoptotic and necrotic cell death during hepatic ischemia/reperfusion injury in mice.HMGB1 contributes to kidney ischemia reperfusion injury.HMGB1 in health and disease.DNA attenuates enterocyte Toll-like receptor 4-mediated intestinal mucosal injury after remote trauma.Ischemia-reperfusion lung injury is attenuated in MyD88-deficient mice.Natural killer cell-dependent anti-fibrotic pathway in liver injury via Toll-like receptor-9.Toll-like receptor 9 deficiency protects mice against Pseudomonas aeruginosa lung infectionLeukocyte transmigration across endothelial and extracellular matrix protein barriers in liver ischemia/reperfusion injury.T-cell immunoglobulin and mucin domain 4 (TIM-4) signaling in innate immune-mediated liver ischemia-reperfusion injury.Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice.Chinese Herbal Preparation Xuebijing Potently Inhibits Inflammasome Activation in Hepatocytes and Ameliorates Mouse Liver Ischemia-Reperfusion Injury.TLR9 Mediates Remote Liver Injury following Severe Renal Ischemia ReperfusionToll-like receptors in ischaemia and its potential role in the pathophysiology of muscle damage in critical limb ischaemia.Mitochondrial Damage-Associated Molecular Patterns (MTDs) Are Released during Hepatic Ischemia Reperfusion and Induce Inflammatory Responses.Ischemia/Reperfusion injury in liver surgery and transplantation: pathophysiologyCalcium/calmodulin-dependent protein kinase IV limits organ damage in hepatic ischemia-reperfusion injury through induction of autophagy.Mammalian DNA is an endogenous danger signal that stimulates local synthesis and release of complement factor B.Nilotinib protects the murine liver from ischemia/reperfusion injury.Intravital Imaging of Neutrophil Recruitment Reveals the Efficacy of FPR1 Blockade in Hepatic Ischemia-Reperfusion Injury.Alveolar macrophages and Toll-like receptor 4 mediate ventilated lung ischemia reperfusion injury in miceTLR9 is dispensable for intestinal ischemia/reperfusion-induced tissue damageMicroRNA-146a-mediated downregulation of IRAK1 protects mouse and human small intestine against ischemia/reperfusion injuryOxidized extracellular DNA as a stress signal in human cellsA novel small-molecule enantiomeric analogue of traditional (-)-morphinans has specific TLR9 antagonist properties and reduces sterile inflammation-induced organ damage.Innate immunity in alcoholic liver disease.
P2860
Q26746467-7F997583-E3A8-4887-8657-2FF229C1BE12Q26778553-E0F47E7C-237D-4588-A445-7519E0203E16Q26849214-BA8E8582-F599-46D4-9DF3-56620C8DFADBQ26996320-41962E01-8604-4329-856C-EADE6293C70EQ27013790-685F2357-EE64-44E1-BA14-668EEF00524DQ27333707-7EF09DC7-B5A0-4BA5-85FC-7D0A2C6A5F3FQ27334890-83D08839-6D84-4A00-ADBA-8EF354D67AECQ28070077-5AC4E13B-6CEF-4088-80E9-AAC47B0636E7Q28080920-3C758FA8-86D0-469E-A96D-E08B4AB1C58CQ33755829-5F315280-83BE-48D0-AEEE-D04D6021DC66Q33847610-A56D1D26-94A9-43C7-97A9-068531F786AFQ33895294-A0F89B04-2261-4CA8-BE01-65AEF02DF433Q33928402-5AB7B784-5AA9-4F67-AA02-E9CB51961E3DQ34400381-3E38E8F4-E635-4DD1-BADF-47FE3C5E5EE4Q34420799-039734A7-9E55-4BB2-955D-933BA3FD04B8Q34422178-98826437-D9D2-447B-AB87-4D7CD01B3540Q34457038-0A338A06-A0D7-4F19-9BE0-29DC1741136BQ34622835-8D56FE10-977B-420A-BF61-3A9849CD3559Q34979970-50012EFE-2F21-4DD1-B93C-302301825E79Q35023053-13816E79-AF64-4D4B-9877-CF5AF11AAA47Q35067837-DB943029-80CE-41E8-B364-AD79A4E3AED2Q35111205-50800EA5-D34F-430A-8428-7AF48B7E611DQ35167030-CB8F3DB0-B7D8-4F11-8935-A784CC77AF41Q35415661-C6AE2B10-762B-496D-B927-DB46E1BC8720Q35541859-D38B8BFC-92C3-447E-9356-81A10A6511A3Q35680107-9D43BD0E-FCCF-4A51-9E17-59FB83D313BDQ35770897-9335068C-CAA3-4AD8-912B-FE5F30B9B2DBQ35791682-0ED29AD6-6AA1-48B4-9708-53727F31E50EQ35801414-1709EBA9-6A53-4A71-9101-9545D3F56AD7Q36014368-57738F70-0371-4554-A23A-C82DB6620E61Q36114899-33AA1D11-B733-405C-B290-68581818D1C6Q36130914-1051F5AD-5473-49E9-86C7-E9A0DEDC4495Q36219461-DC30C062-E0B6-4792-AC77-BD017D40E1ECQ36243534-55AEE83A-5AFF-457A-BE0E-236C77487FFCQ36337746-418D30F6-2E6B-409E-996D-4B726AEA8FA5Q36431855-5018BA46-2BC1-4214-9C5C-82BE66EB8035Q36492395-E82926AE-E4E4-4227-B87F-275A61FA70E2Q36711791-66C67AEA-923E-4854-9484-3A2A3859F3DAQ37081728-337A9D9A-A44D-4F62-94AA-0FA8046ED985Q37174755-D94A5408-1420-4B26-AD44-964C387BD424
P2860
Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Toll-like receptor 9 inhibitio ...... r ischemia-reperfusion injury.
@en
type
label
Toll-like receptor 9 inhibitio ...... r ischemia-reperfusion injury.
@en
prefLabel
Toll-like receptor 9 inhibitio ...... r ischemia-reperfusion injury.
@en
P2093
P2860
P356
P1433
P1476
Toll-like receptor 9 inhibitio ...... r ischemia-reperfusion injury.
@en
P2093
George Plitas
Hebroon Obaid
Lee M Ocuin
Ronald P DeMatteo
Vinod P Balachandran
Zubin M Bamboat
P2860
P304
P356
10.1002/HEP.23365
P407
P577
2010-02-01T00:00:00Z